INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Quicker Development Using Cell Line Integration, End-To-End Support")
Quicker Development Using Cell Line Integration, End-To-End SupportDespite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
![Assessing Nephrotoxicity and Drug-Drug Interactions]( "Assessing Nephrotoxicity And Drug-Drug Interactions")
Assessing Nephrotoxicity And Drug-Drug InteractionsWatch to discover how Organ-on-a-Chip technology can help you overcome the limitations of traditional kidney models and increase your confidence before advancing your drug candidate to the clinic.
-
![Using Residual DNA Quantification Data To De-risk mAb Development Bucket]( "Using Residual DNA Quantification Data To De-Risk mAb Development")
Using Residual DNA Quantification Data To De-Risk mAb DevelopmentResidual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
-
![Microglia]( "Microglia: Where We Came From And Where We Are Now")
Microglia: Where We Came From And Where We Are NowGain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.
-
Engineering The Future Of Lipsomal Drug Delivery5/14/2025
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
The Role Of Peptones In Boosting Quality And Yield11/4/2024
Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?11/13/2024
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Temperature Dependence On Reversed-Phase Separations7/17/2025
Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.
-
Optical Microscopy For Process Monitoring And Product Characterization3/9/2026
Modern optical microscopy reveals cellular activity and material quality with exceptional clarity. See how tailored, feature‑rich imaging systems help researchers generate high‑value data.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-dm-2000-hero]( "Ergonomic System Microscopes")
Leica DM2000
With their sophisticated modular design and high-performance fluorescence, the Leica DM2000 microscopes are ideal for complex tasks in pathology, cytology, and many other applications. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
![peptide-cdmo-GettyImages-185209542]( "Peptide CDMO Services")
Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.
-
![Female researcher analyzing scientific samples-GettyImages-2231025177]( "Curia R&D Pipeline Overview")
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
